Dutch guidelines for diagnosis and therapy of proliferative lupus nephritis

被引：1

作者：

van Tellingen, A. ^{[1
]}

Voskuyl, A. E. ^{[2
]}

Vervloet, M. G. ^{[1
]}

Bijl, M. ^{[3
]}

de Sevaux, R. G. L. ^{[4
]}

Berger, S. P. ^{[5
]}

Derksen, R. H. W. M. ^{[6
]}

Berden, J. H. M. ^{[4
]}

机构：

[1] Vrije Univ Amsterdam Med Ctr, Dept Nephrol, Amsterdam, Netherlands

[2] Vrije Univ Amsterdam Med Ctr, Dept Rheumatol, Amsterdam, Netherlands

[3] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, NL-9713 AV Groningen, Netherlands

[4] Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, NL-6525 ED Nijmegen, Netherlands

[5] Univ Med Ctr Rotterdam, Erasmus MC, Dept Internal Med, Rotterdam, Netherlands

[6] Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands

来源：

NETHERLANDS JOURNAL OF MEDICINE | 2012年 / 70卷 / 04期

关键词：

Azathioprine; cyclophosphamide; mycophenolate mofetil; proliferative lupus nephritis; TERM-FOLLOW-UP; MYCOPHENOLATE-MOFETIL; LONG-TERM; IMMUNOSUPPRESSIVE THERAPY; PULSE CYCLOPHOSPHAMIDE; EULAR RECOMMENDATIONS; INDUCTION THERAPY; CONTROLLED-TRIAL; CLINICAL-TRIALS; ERYTHEMATOSUS;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Proliferative lupus nephritis is a strong predictor of morbidity and mortality in patients with systemic lupus erythematosus. Despite improvements in the management of lupus nephritis, a significant number of the patients do not respond to immunosuppressive therapy and progress to end-stage renal failure. In order to optimise the diagnostic strategy and treatment of patients with proliferative lupus nephritis, guidelines are needed. In this review, the Dutch Working Party on Systemic Lupus Erythematosus provides recommendations regarding four important areas in patients with proliferative lupus nephritis: I) indications for a first renal biopsy, II) definitions of treatment response, III) selection of treatment options, and IV) indications for a repeat biopsy.

引用

页码：199 / 206

页数：8

共 50 条

[1] Therapy for Proliferative Lupus Nephritis
Meliambro, Kristin
Campbell, Kirk N.
Chung, Miriam
[J]. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2018, 44 (04) : 545 - +
[2] Induction and maintenance therapy in proliferative lupus nephritis
Ponticelli, Claudio
Glassock, Richard J.
Moroni, Gabriella
[J]. JOURNAL OF NEPHROLOGY, 2010, 23 (01) : 9 - 16
[3] DISCONTINUATION OF THERAPY IN DIFFUSE PROLIFERATIVE LUPUS NEPHRITIS
PONTICELLI, C
MORONI, G
BANFI, G
[J]. AMERICAN JOURNAL OF MEDICINE, 1988, 85 (02): : 275 - 275
[4] Dutch lupus nephritis study I: Comparison of azathioprine/methylprednisolone with cyclophosphamide pulses in proliferative lupus nephritis.
Grootscholten, C
Ligtenberg, G
van Houwelingen, J
Derksen, R
Berden, J
[J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S412 - S412
[5] Cyclophosphamide versus azathioprine for proliferative lupus nephritis therapy
[J]. Nature Clinical Practice Nephrology, 2006, 2 (12): : 661 - 662
[6] PULSE METHYLPREDNISOLONE THERAPY IN DIFFUSE PROLIFERATIVE LUPUS NEPHRITIS
BARRON, KS
PERSON, DA
BREWER, EJ
BEALE, MG
ROBSON, AM
[J]. JOURNAL OF PEDIATRICS, 1982, 101 (01): : 137 - 141
[7] Cyclophosphamide versus azathioprine for proliferative lupus nephritis therapy
不详
[J]. Nature Clinical Practice Rheumatology, 2006, 2 (11): : 661 - 662
[8] Commentary on the Current Guidelines for the Diagnosis of Lupus Nephritis Flare
Isabelle Ayoub
Dan Birmingham
Brad Rovin
Lee Hebert
[J]. Current Rheumatology Reports, 2019, 21
[9] Commentary on the Current Guidelines for the Diagnosis of Lupus Nephritis Flare
Ayoub, Isabelle
Birmingham, Dan
Rovin, Brad
Hebert, Lee
[J]. CURRENT RHEUMATOLOGY REPORTS, 2019, 21 (04)
[10] Management of proliferative lupus nephritis
Monroy Trujillo, Jose M.
Fine, Derek M.
[J]. PANMINERVA MEDICA, 2016, 58 (04) : 286 - 293

← 1 2 3 4 5 →